Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Interest Expenses (2010 - 2026)

Vericel (VCEL) posted Interest Expenses of $625000.0 for Q2 2026, little changed sequentially from $625000.0 in Q1 2026, and little changed YoY from $625000.0 in Q2 2025.

Analysis

Vericel (VCEL) Interest Expenses (2010 - 2026) Analysis & Trends

Vericel has reported Interest Expenses for 17 years, with the latest figure at $625000.0 in Q2 2026.

  • Quarterly Interest Expenses changed 0.0% year-over-year to $625000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $625000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $41.2 million, down 70.01% from the prior year.
  • Interest Expenses was little changed at $625000.0 in Q2 2026 per VCEL's latest filing, from $625000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $159.5 million in Q2 2023 and troughed at $18000.0 in Q1 2022.
  • A 5-year average of $18.1 million and a median of $625000.0 in 2023 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2023 and 2024: Interest Expenses soared 797625.0% in 2023, then plunged 99.61% in 2024.
  • Over 5 years, Interest Expenses stood at $223000.0 in 2022, then tumbled by 30.04% to $156000.0 in 2023, then surged by 438.46% to $840000.0 in 2024, then advanced by 22.86% to $1.0 million in 2025, then sank by 39.44% to $625000.0 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $625000.0, $625000.0, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160,000.00
Mar 31, 2026 160,000.00
Dec 31, 2025 162,000.00
Sep 30, 2025 158,000.00
Jun 30, 2025 157,000.00
Mar 31, 2025 153,000.00
Dec 31, 2024 154,000.00
Sep 30, 2024 154,000.00
Jun 30, 2024 153,000.00
Mar 31, 2024 153,000.00
Dec 31, 2023 156,000.00
Sep 30, 2023 150,000.00
Jun 30, 2023 149,000.00
Mar 31, 2023 145,000.00
Dec 31, 2022 223,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 20,000.00
Mar 31, 2022 18,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 1,000.00